Skip to main navigation Skip to search Skip to main content

Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons

  • Sebastiano Cavallaro
  • , Agata Copani
  • , Velia D'Agata
  • , Simone Musco
  • , Salvatore Petralia
  • , Carmelo Ventra
  • , Franca Stivala
  • , Salvatore Travali
  • , Pier Luigi Canonico

Research output: Contribution to journalArticlepeer-review

Abstract

The two forms of pituitary adenylate cyclase-activating polypeptide, PACAP27 and PACAP38, are two neuropeptide hormones related to the vasoactive intestinal peptide/secretin/glucagon family of peptides. PACAP receptors that are positively coupled to adenylyl cyclase and phospholipase C have been identified in cultured cerebellar granule cells. Using the reverse transcription-polymerase chain reaction methodology, we demonstrated the expression of the PACAP-R and PACAP-R-hop mRNAs in cultured granule cells. When grown in the absence of serum or in low K+ concentrations, these neurons underwent apoptosis, a naturally occurring process characterized by cell shrinkage and internucleosomal DNA cleavage. We used these models of programmed cell death to study the relationship between PACAP receptor activation and neuronal apoptosis. Treatment with PACAP27 and PACAP38 reduced the development of apoptosis in a dose-dependent manner. The neuroprotective activity of PACAP was mimicked by high concentrations of vasoactive intestinal peptide or forskolin but not by carbamylcholine. Thus, we suggest that the activation of type I PACAP receptors may contribute to the survival of cerebellar granule neurons.

Original languageEnglish
Pages (from-to)60-66
Number of pages7
JournalMolecular Pharmacology
Volume50
Issue number1
DOIs
Publication statusPublished - Jul 1996
Externally publishedYes

Fingerprint

Dive into the research topics of 'Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons'. Together they form a unique fingerprint.

Cite this